The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
Open accessAbstract
BACKGROUND AND AIMS: Proton pump inhibitors (PPIs) have been associated with adverse clinical outcomes amongst clopidogrel users after an acute coronary syndrome. Recent pre-clinical results suggest that this risk might extend to subjects without any prior history of cardiovascular disease. We explore this potential risk in the general population via data-mining approaches. METHODS: Using a novel approach for mining clinical data for pharmacovigilance, we queried over 16 million clinical documents on 2.9 million individuals to examine whether PPI usage was associated with cardiovascular risk in the general population. RESULTS: In multiple data sources, we found gastroesophageal reflux disease (GERD) patients exposed to PPIs to have a 1.16 fold increased association (95% CI 1.09-1.24) with myocardial infarction (MI). Survival analysis in a prospective cohort found a two-fold (HR = 2.00; 95% CI 1.07-3.78; P = 0.031) increase in association with cardiovascular mortality. We found that this association exists regardless of clopidogrel use. We also found that H2 blockers, an alternate treatment for GERD, were not associated with increased cardiovascular risk; had they been in place, such pharmacovigilance algorithms could have flagged this risk as early as the year 2000. CONCLUSIONS: Consistent with our pre-clinical findings that PPIs may adversely impact vascular function, our data-mining study supports the association of PPI exposure with risk for MI in the general population. These data provide an example of how a combination of experimental studies and data-mining approaches can be applied to prioritize drug safety signals for further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)
Breiman, L. (2001) · Statistical Science · doi:10.1214/ss/1009213726 · Cited by 4,340
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
The Unreasonable Effectiveness of Data
Halevy, A., Norvig, P., & Pereira, F. (2009) · IEEE Intelligent Systems · doi:10.1109/mis.2009.36 · Cited by 1,767
Statistical modeling: The two cultures
Breiman, L. (2001) · Cited by 1,314
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
Gilard, M., Arnaud, B., Cornily, J.-C., Le Gal, G., Lacut, K., Le Calvez, G., Mansourati, J., Mottier, D., Abgrall, J.-F., & Boschat, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.064 · Cited by 1,015
Ho, P. M. (2009) · JAMA · doi:10.1001/jama.2009.261 · Cited by 1,007
O'Donoghue, M. L., Braunwald, E., Antman, E. M., Murphy, S. A., Bates, E. R., Rozenman, Y., Michelson, A. D., Hautvast, R. W., Ver Lee, P. N., Close, S. L., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61525-7 · Cited by 725
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Achieving a Nationwide Learning Health System
Friedman, C. P., Wong, A. K., & Blumenthal, D. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001456 · Cited by 539
Economics in the age of big data
Einav, L., & Levin, J. (2014) · Science · doi:10.1126/science.1243089 · Cited by 498
STRIDE--An integrated standards-based translational research informatics platform.
Lowe, H., Ferris, T., Hernandez, P. M., & Weber, S. (2009) · PubMed · Cited by 397
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Self-citationLewandowsky, S. (2015) · Bristol Research (University of Bristol) · doi:10.5523/bris.swyt56qr4vaj17op9cw3sag7d · Cited by 369
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
Holmes, D. R., Dehmer, G. J., Kaul, S., Leifer, D., O’Gara, P. T., & Stein, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.013 · Cited by 354
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Tran, C. T. L., Leiper, J. M., & Vallance, P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 314
Ito, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Charlot, M., Ahlehoff, O., Norgaard, M. L., Jørgensen, C. H., Sørensen, R., Abildstrøm, S. Z., Hansen, P. R., Madsen, J. K., Køber, L., Torp-Pedersen, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-6-201009210-00005 · Cited by 264
Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., Leiper, J., & Cooke, J. P. (2013) · Circulation · doi:10.1161/circulationaha.113.003602 · Cited by 255
Self-citationCharlot, M., Grove, E. L., Hansen, P. R., Olesen, J. B., Ahlehoff, O., Selmer, C., Lindhardsen, J., Madsen, J. K., Kober, L., Torp-Pedersen, C., et al. (2011) · BMJ · doi:10.1136/bmj.d2690 · Cited by 199
Goodman, S. G., Clare, R., Pieper, K. S., Nicolau, J. C., Storey, R. F., Cantor, W. J., Mahaffey, K. W., Angiolillo, D. J., Husted, S., Cannon, C. P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.032912 · Cited by 194
Pharmacovigilance Using Clinical Notes
LePendu, P., Iyer, S. V., Bauer-Mehren, A., Harpaz, R., Mortensen, J. M., Podchiyska, T., Ferris, T. A., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.47 · Cited by 161
Self-citationSimon, T., Steg, P. G., Gilard, M., Blanchard, D., Bonello, L., Hanssen, M., Lardoux, H., Coste, P., Lefèvre, T., Drouet, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.965640 · Cited by 159
Mittermayer, F., Krzyżanowska, K., Exner, M., Mlekusch, W., Amighi, J., Sabeti, S., Minar, E., Müller, M. M., Wolzt, M., & Schillinger, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242801.38419.48 · Cited by 144
Maggio, M. G., Corsonello, A., Ceda, G. P., Cattabiani, C., Lauretani, F., Buttò, V., Ferrucci, L., Bandinelli, S., Abbatecola, A. M., Spazzafumo, L., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2851 · Cited by 124
Dayal, S., & Lentz, S. R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm599oa · Cited by 113
Katz, M. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.64 · Cited by 105
Proton pump inhibitor use represents an independent risk factor for myocardial infarction
Shih, C.-J., Chen, Y.-T., Ou, S., Li, S., Chen, T., & Wang, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.036 · Cited by 105
Coloma, P. M., Avillach, P., Salvo, F., Schuemie, M. J., Ferrajolo, C., Pariente, A., Fourrier‐Réglat, A., Molokhia, M., Patadia, V. K., van der Lei, J., et al. (2012) · Drug Safety · doi:10.1007/s40264-012-0002-x · Cited by 100
Douglas, I., Evans, S., Hingorani, A., Grosso, A., Timmis, A., Hemingway, H., & Smeeth, L. (2012) · British medical journal · doi:10.1136/bmj.e4388 · Cited by 96
Lu, T., Chung, M., Lin, M., Hsu, C., & Lin, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.120 · Cited by 79
Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes
Leeper, N. J., Bauer‐Mehren, A., Iyer, S. V., LePendu, P., Olson, C., & Shah, N. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063499 · Cited by 76
Self-citationWilson, A., Shin, D. S., Weatherby, C., Harada, R. K., Ng, M. K., Nair, N., Kielstein, J. T., & Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10364552 · Cited by 67
Self-citationAlternative Ankle-Brachial Index Method Identifies Additional At-Risk Individuals
Nead, K. T., Cooke, J. P., Olin, J. W., & Leeper, N. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.061 · Cited by 55
Self-citationProton pump inhibitor side effects and drug interactions: Much ado about nothing?
Madanick, R. D. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10087 · Cited by 53
Schillinger, W., Teucher, N., Sossalla, S. T., Kettlewell, S., Werner, C., Raddatz, D., Elgner, A., Tenderich, G., Pieske, B. M., Ramadori, G. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.666008 · Cited by 51
Cooke, J. P., & Ghebremariam, Y. T. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228833 · Cited by 49
Self-citationA novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine
Arı, H., Arı, S., Erdoğan, E., Tiryakioğlu, O., Üstündağ, Y., Huysal, K., Koca, V., & Bozat, T. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1158-x · Cited by 38
Nead, K., Zhou, M., Caceres, R. D., Sharp, S., Wehner, M., Olin, J., Cooke, J., & Leeper, N. (2013) · American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.055 · Cited by 24
Self-citationAdvancing the Science of Pharmacovigilance
Honig, P. K. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.60 · Cited by 22
dos Santos, Y. D. A. P., Younes-Ibrahim, M. S., Crozatti, L. L., Raglione, D., Cardozo, L. C. M., Besen, B. A. M. P., Taniguchi, L. U., Park, M., & Mendes, P. V. (2020) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20200007 · Cited by 22
DDAH: A target for vascular therapy?
Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10362605 · Cited by 17
Self-citationSossalla, S. T., Schotola, H., Schmitto, J. D., Toischer, K., Sohns, C., Schwörer, H., Hasenfuss, G. P., Maier, L. S., & Schillinger, W. (2011) · PubMed · Cited by 15
Arteriosclerosis, Thrombosis, and Vascular Biology , 2006
Heistad, D. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000198400.82143.3b · Cited by 14
Iyer, S. V., LePendu, P., Harpaz, R., Bauer‐Mehren, A., & Shah, N. H. (2013) · Europe PMC (PubMed Central) · Cited by 12
Self-citationOudit, G. Y., Bakal, J. A., McAlister, F. A., & Ezekowitz, J. A. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr104 · Cited by 11
Maggio, M. G., & Corsonello, A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.8459 · Cited by 2
Cited by
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8581 · Cited by 658
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Metadata
- Authors
- Shah, N. H., LePendu, P., Bauer-Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J., Nead, K. T., Cooke, J. P., & Leeper, N. J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-10
- Volume
- 10
- Issue
- 6
- Pages
- e0124653
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2134027168
- Cited by
- 335
- References
- 49
- FWCI
- 37.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.